Delivery Order SPE2DB24D1205-SPE2DB24FCTDS
Award Date
7/29/24
Potential Completion Date
8/19/24
Potential Value
$13K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Zeposia 0.92 mg capsules, a medication used to treat certain medical conditions. The contract has a firm fixed price of $13,862.79 and a completion date of July 22, 2025. It is not designated as a set-aside contract, indicating open competition. AmerisourceBergen Drug Corp...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of the medication Zeposia 0.92 mg Capsule 30s, with a ceiling value of $13,862.79 and a performance period through May 21, 2025. This contract is not set-aside and was awarded as part of AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $13,862.79 fixed-price contract is for the supply of the prescription medication Zeposia 0.92 mg capsules. The contract has an ultimate completion date of May 20, 2025. AmerisourceBergen Drug Corp holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a comprehensive global...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation's Corporate Office division. The $13,399.71 firm fixed price contract is for the supply of Zeposia 0.92 MG capsules. Zeposia is a prescription medication used to treat certain medical conditions. This contract is not set aside for a specific type of business. Amerisourcebergen is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, including...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office division, a major pharmaceutical distributor. The $4,466.57 firm-fixed-price contract is for the supply of the prescription medication Zeposia 0.92 MG Capsule 30S. The award is associated with a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for delivering a...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $26,799.42 delivery order is for the medication Zeposia 0.92 MG Capsule 30S and has a completion date of May 14, 2024. This award is a child contract under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 with DLA Troop Support Medical, which provides a wide range of pharmaceutical products and medical supplies to military healthcare...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Zeposia 0.92 mg capsules in 30-count packages, with a ceiling value of $4,620.93 and a final completion date of July 25, 2025. The contract is a firm-fixed-price type and is not set aside for any specific business category. AmerisourceBergen Drug Corp holds a significant...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Zeposia 0.92 mg capsules. The contract has a firm fixed price of $13,862.79 and a performance period ending on July 30, 2025. The contract is not set aside and is an open competition award. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, from the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the delivery of Zeposia 0.92 mg capsules, valued at $8,933.14. This is a firm fixed-price delivery order contract with an ultimate completion date of August 23, 2024. The award does not utilize a set-aside designation. AmerisourceBergen holds several Indefinite Delivery Contracts (IDCs) with the DLA and other...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Zeposia 0.92 mg capsules, a pharmaceutical product. The delivery order has a ceiling value of $13,862.79 and is a firm fixed-price contract. The contract is not set aside and is therefore open to full and open competition. Amerisourcebergen Drug Corp holds a significant...